Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retention (UR); and rechargeable (R20) and recharge-free (F15) implantable SNM systems that delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of OAB, UR, and FI. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct sales force and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2024-11-04 |
2024-09 |
0.13 |
N/A |
N/A |
N/A |
2024-08-01 |
2024-06 |
0.08 |
0.13 |
0.05 |
62.50% |
2024-04-30 |
2024-03 |
-0.05 |
-0.38 |
-0.33 |
-660.00% |
2024-04-30 |
2024-03 |
-0.05 |
N/A |
N/A |
N/A |
2024-02-28 |
2023-12 |
0.06 |
N/A |
N/A |
N/A |
2024-02-28 |
2023-12 |
0.06 |
0.13 |
0.07 |
116.67% |
Date |
Firm |
Action |
From |
To |
2023-10-15 |
Leerink Partners |
Upgrade |
|
Outperform |
2023-07-27 |
Baird |
Upgrade |
Outperform |
Outperform |
2023-07-27 |
Needham |
Upgrade |
Buy |
Buy |
2023-07-27 |
Keybanc |
Upgrade |
Overweight |
Overweight |
2023-07-18 |
Baird |
Upgrade |
|
Outperform |
2023-07-13 |
Mizuho |
Upgrade |
Buy |
Buy |
Date |
Name |
Relation |
Quantity |
Description |
2023-08-07 |
CARREL MICHAEL H |
Director |
17.86K |
Stock Gift |
2024-07-23 |
COHEN RAYMOND W |
Chief Executive Officer |
292.73K |
Conversion of Exercise of derivative security |
2023-09-28 |
DEAREN DANNY L |
President |
23.78K |
Sale |
2024-01-30 |
FORD ALFRED J. JR |
Officer |
43.45K |
Sale |
2024-01-30 |
KEESE KARI LEIGH |
Chief Financial Officer |
43.32K |
Sale |
2023-06-25 |
MCNAMARA ROBERT E |
Director |
14.86K |
Stock Award(Grant) |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Vanguard Group Inc |
5.33M |
269.22M |
10.57% |
2023-06-29 |
Blackrock Inc. |
3.76M |
189.95M |
7.46% |
2023-06-29 |
FMR, LLC |
2.65M |
133.92M |
5.26% |
2023-06-29 |
Bellevue Group AG |
2.22M |
112.22M |
4.41% |
2023-06-29 |
BAMCO Inc. |
1.80M |
90.96M |
3.57% |
2023-06-29 |
Champlain Investment Partners, LLC |
1.74M |
87.89M |
3.45% |
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Vanguard Total Stock Market Index Fund |
1.55M |
78.31M |
3.07% |
2023-06-29 |
Vanguard Small-Cap Index Fund |
1.30M |
65.65M |
2.58% |
2023-08-30 |
iShares Russell 2000 ETF |
1.12M |
64.01M |
2.21% |
2023-06-29 |
Baron Small Cap Fund |
1000.00K |
50.47M |
1.98% |
2023-05-30 |
Invesco Discovery Fund |
995.56K |
48.18M |
1.97% |
2023-06-29 |
Vanguard Small-Cap Growth Index Fund |
744.96K |
37.60M |
1.48% |